CELLI, MONICA
CELLI, MONICA
Mostra
records
Risultati 1 - 3 di 3 (tempo di esecuzione: 0.027 secondi).
Correlation of [68Ga]Ga-PSMA PET/CT response and clinical outcomes in patients treated with enzalutamide as first-line therapy for metastatic castration-resistant prostate cancer (mCRPC): Results of a prospective study
2024 Francesco Giunta, Emilio; Caroli, Paola; Scarpi, Emanuela; Altavilla, Amelia; Marini, Irene; Celli, Monica; Casadei, Chiara; Lolli, Cristian; Schepisi, Giuseppe; Bleve, Sara; Brighi, Nicole; Concetta Cursano, Maria; Martinelli, Giovanni; Matteucci, Federica; De Giorgi, Ugo Federico Francesco
PSMA expression: A potential ally for the pathologist in prostate cancer diagnosis
2018 Bravaccini S.; Puccetti M.; Bocchini M.; Ravaioli S.; Celli M.; Scarpi E.; De Giorgi U.; Tumedei M.M.; Raulli G.; Cardinale L.; Paganelli G.
Single-Agent Lenalidomide Is Effective in the Treatment of a Heavily Pretreated and Refractory Angioimmunoblastic T-Cell Lymphoma Patient.
2014 Broccoli A;Pellegrini C;Celli M;Argnani L;Agostinelli C;Pileri S;Zinzani PL
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Correlation of [68Ga]Ga-PSMA PET/CT response and clinical outcomes in patients treated with enzalutamide as first-line therapy for metastatic castration-resistant prostate cancer (mCRPC): Results of a prospective study | Francesco Giunta, Emilio; Caroli, Paola; Scarpi, Emanuela; Altavilla, Amelia; Marini, Irene; Cell...i, Monica; Casadei, Chiara; Lolli, Cristian; Schepisi, Giuseppe; Bleve, Sara; Brighi, Nicole; Concetta Cursano, Maria; Martinelli, Giovanni; Matteucci, Federica; De Giorgi, Ugo Federico Francesco | 2024-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| PSMA expression: A potential ally for the pathologist in prostate cancer diagnosis | Bravaccini S.; Puccetti M.; Bocchini M.; Ravaioli S.; Celli M.; Scarpi E.; De Giorgi U.; Tumedei ...M.M.; Raulli G.; Cardinale L.; Paganelli G. | 2018-01-01 | SCIENTIFIC REPORTS | - | 1.01 Articolo in rivista | - |
| Single-Agent Lenalidomide Is Effective in the Treatment of a Heavily Pretreated and Refractory Angioimmunoblastic T-Cell Lymphoma Patient. | Broccoli A;Pellegrini C;Celli M;Argnani L;Agostinelli C;Pileri S;Zinzani PL | 2014-01-01 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | - | 1.01 Articolo in rivista | - |